Effectiveness of Treating Patients with Stable Ischemic Heart Disease and Co-Existent Paroxysmal Atrial Fibrillation with Mebicar
Atrial fibrillation is a disturbance of heart rhythm, which is characterized by frequent contractions of atrial muscle fibers. Stable ischemic heart disease, arterial hypertension, heart failure, obesity are risk factors for progression of atrial fibrillation. Psycho-emotional stress, anxiety and depression can be the cause of atrial fibrillation paroxysm as well.
The objective of the research was to study the effect of mebicаr in the treatment of paroxysmal atrial fibrillation considering anxiety-depressive symptoms.
Materials and Methods. Observations were performed on patients with stable ischemic heart disease and co-existent paroxysmal atrial fibrillation using clinico-psychopathological research method (structured interview). The level of stress was determined on the L. Rider scale and the 10-Item perceived stress scale; the level of anxiety and depression was determined by means of the Hospital Anxiety and Depression Scale and the Patient Health Questionnaire-9. The evaluation of the free radical oxidation state was carried out using a spectrophotometric method to determine the activity of catalase, glutathione peroxidase, superoxide dismutase in the blood serum.
Results. As a result of the analysis, it was found that the higher the level of anxiety-depressive disorders, the more frequent paroxysms of atrial fibrillation. High level of stress was found in 37.50% of men (p<0.01) and 31.25% of women (p<0.05) in Group 2b. The manifestations of the clinical level of anxiety and depression in men of Group 2b (p<0.05) were detected.
Conclusions. The analysis of electrocardiogram indices showed the signs of atrial fibrillation (p<0.05), repolarization abnormalities (p<0.001), left ventricular hypertrophy (p<0.05), and the appearance of extrasystoles (p<0.001). Echocardiographic indices showed the signs of diffuse cardiosclerosis, severe left atrial dilatation (p<0.05) and reduced myocardial contractility, which was statistically confirmed. The use of anxiolytic medication – mebicar – during treatment helped significantly improve the clinical and hemodynamic parameters, which confirmed treatment effectiveness.
Ermashkin VI. Predpolagayemyy mekhanizm vozniknoveniya aritmiyi serdtsa cheloveka. The Journal of scientific articles "Health and Education millennium" 2013;15(6):1-11.
Filippova MO. Analysis of the indicators of protein and lipid oxidative stress in patients with atrial fibrillation in combination with and without effort angina. Astrakhan Medical Journal. 2018;1(13):1-8. [published in Russian]
Lukashenko AA. The role of emotional stress in the genesis of life-hreatening heart rhythm disorders. RUDN Journal of Medicine. 2014;2:35-41. [published in Russian]
Philippova MO, Polunina OS, Voronina IP et al. The prognosis of development of the paroxysm of atrial fibrillation in patients with post-infarction cardiosclerosis. Kuban Scientific Medical Bulletin. 2017;(3):114-119. [published in Russian] DOI: https://doi.org/10.25207/1608-6228-2017-24-3-114-119
Troshina DV, Volel BA. Stress-induced atrial fibrillation. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(1):6-13. [published in Russian] DOI: https://doi.org/10.17116/jnevro20191190116 [PMid:30778024]
Severino P, Mariani V. Triggers for Atrial Fibrillation: The Role of Anxiety. Cardiology Research and Practice. 2019;5. DOI: https://doi.org/10.1155/2019/1208505 [PMid:30906592 PMCid:PMC6398072]
Gorokhova SG. Cardiovascular continuum possibilities of coenzyme Q10 in correction of oxidative stress. Cardiology. 2011;51(10):61-65. [published in Russian]
Filippova MO. Oxidative stress in patients with atrial fibrillation and postinfarction cardiosclerosis. Modern problems of science and education. 2016;6:65. [published in Russian]
Karpukhina OV. Analisis of metal-induced oxidative stress in unicellular organims. Fundamental research. 2013;11:671-674. [published in Russian]
Copyright (c) 2019 Lesia Serediuk, Ihor Vakalyuk, Ulyana Tsimbalyuk, Lesia Bila
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).